Linus Backert

2.2k total citations · 1 hit paper
18 papers, 1.0k citations indexed

About

Linus Backert is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Linus Backert has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Linus Backert's work include Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Linus Backert is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Linus Backert collaborates with scholars based in Germany, Switzerland and United States. Linus Backert's co-authors include Oliver Kohlbacher, Hans‐Georg Rammensee, Heiko Schuster, Stefan Stevanović, Henoch S. Hong, Ulrike Gnad-Vogt, Sven D. Koch, Mariola Fotin‐Mleczek, Ingmar Hoerr and Greg Finak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Linus Backert

18 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

2017 373 citations Martin Alberer, Ulrike Gnad-Vogt et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linus Backert Germany	13	652	457	299	226	136	18	1.0k
Elise Landais United States	16	363 0.6×	977 2.1×	462 1.5×	284 1.3×	229 1.7×	26	1.6k
Paul A Santini United States	8	524 0.8×	1.0k 2.2×	187 0.6×	110 0.5×	114 0.8×	12	1.7k
Peter H. Goff United States	18	686 1.1×	520 1.1×	201 0.7×	312 1.4×	73 0.5×	39	1.4k
Maxime Moulard France	16	378 0.6×	565 1.2×	380 1.3×	121 0.5×	225 1.7×	37	1.3k
Cynthia de la Fuente United States	25	586 0.9×	564 1.2×	426 1.4×	156 0.7×	31 0.2×	37	1.5k
David Feltquate United States	14	373 0.6×	576 1.3×	131 0.4×	348 1.5×	79 0.6×	28	1.2k
Antonio Cosma France	22	423 0.6×	695 1.5×	300 1.0×	86 0.4×	32 0.2×	71	1.3k
Uwe Tessmer Germany	18	708 1.1×	285 0.6×	595 2.0×	183 0.8×	38 0.3×	22	1.6k
Mark J. Cayabyab United States	18	579 0.9×	1.6k 3.4×	542 1.8×	388 1.7×	200 1.5×	31	2.5k
Mikyung Kim United States	19	621 1.0×	593 1.3×	257 0.9×	85 0.4×	392 2.9×	26	1.4k

Countries citing papers authored by Linus Backert

Since Specialization

Citations

This map shows the geographic impact of Linus Backert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linus Backert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linus Backert more than expected).

Fields of papers citing papers by Linus Backert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linus Backert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linus Backert. The network helps show where Linus Backert may publish in the future.

Co-authorship network of co-authors of Linus Backert

This figure shows the co-authorship network connecting the top 25 collaborators of Linus Backert. A scholar is included among the top collaborators of Linus Backert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linus Backert. Linus Backert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Marcu, Ana, Leon Bichmann, Lèon Kuchenbecker, et al.. (2020). The HLA Ligand Atlas: A novel immuno-oncology resource for T-cell antigen discovery.. Journal of Clinical Oncology. 38(15_suppl). 3128–3128. 1 indexed citations

Löffler, Markus, Daniel J. Kowalewski, Linus Backert, et al.. (2018). Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation. Cancer Research. 78(16). 4627–4641. 36 indexed citations

Neidert, Marian C., Daniel J. Kowalewski, Manuela Silginer, et al.. (2018). The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy. Acta Neuropathologica. 135(6). 923–938. 29 indexed citations

Walz, Juliane S., Daniel J. Kowalewski, Linus Backert, et al.. (2018). Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. Leukemia & lymphoma. 59(8). 1949–1958. 5 indexed citations

Alberer, Martin, Ulrike Gnad-Vogt, Henoch S. Hong, et al.. (2017). Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. The Lancet. 390(10101). 1511–1520. 373 indexed citations breakdown →

Marco, Moreno Di, Heiko Schuster, Linus Backert, et al.. (2017). Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices. The Journal of Immunology. 199(8). 2639–2651. 68 indexed citations

Fuchs, Stephan, Jörg Bernhardt, Stephan Michalik, et al.. (2017). Aureo Wiki The repository of the Staphylococcus aureus research and annotation community. International Journal of Medical Microbiology. 308(6). 558–568. 87 indexed citations

Haen, Sebastian P., Michael Schumm, Linus Backert, et al.. (2017). Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation. Annals of Hematology. 96(5). 817–827. 15 indexed citations

Backert, Linus, Daniel J. Kowalewski, Simon Walz, et al.. (2017). A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and “pan-leukemia” antigens. Oncotarget. 8(27). 43915–43924. 10 indexed citations

10.

Nelde, Annika, Daniel J. Kowalewski, Linus Backert, et al.. (2017). HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy. OncoImmunology. 7(4). e1316438–e1316438. 28 indexed citations

11.

Oehl, Kathrin, Daniel J. Kowalewski, Moreno Di Marco, et al.. (2016). Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy. PLoS ONE. 11(11). e0167017–e0167017. 17 indexed citations

12.

Kowalewski, Daniel J., Juliane S. Walz, Linus Backert, et al.. (2016). Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini. Blood Cancer Journal. 6(4). e411–e411. 14 indexed citations

13.

Hong, Henoch S., Sven D. Koch, Birgit Scheel, et al.. (2016). Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. OncoImmunology. 5(12). e1249560–e1249560. 18 indexed citations

14.

Nelde, Annika, Daniel J. Kowalewski, Linus Backert, et al.. (2016). HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy. Blood. 128(22). 3234–3234. 3 indexed citations

15.

Backert, Linus & Oliver Kohlbacher. (2015). Immunoinformatics and epitope prediction in the age of genomic medicine. Genome Medicine. 7(1). 119–119. 148 indexed citations

16.

Walz, Simon, Juliane S. Stickel, Daniel J. Kowalewski, et al.. (2015). The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy. Blood. 126(10). 1203–1213. 74 indexed citations

17.

Kowalewski, Daniel J., Heiko Schuster, Linus Backert, et al.. (2014). HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL). Proceedings of the National Academy of Sciences. 112(2). E166–75. 108 indexed citations

18.

Römer, Michael, Linus Backert, Johannes Eichner, & Andreas Zell. (2014). ToxDBScan: Large-Scale Similarity Screening of Toxicological Databases for Drug Candidates. International Journal of Molecular Sciences. 15(10). 19037–19055. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact